Isidro Ferrer Abizanda-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

    Biochemical Pharmacology, Vol. 157, pp. 67-84

2017

  1. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases

    Neurobiology of Aging, Vol. 49, pp. 52-59

  2. Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease

    Frontiers in Bioscience - Scholar, Vol. 9, Núm. 1, pp. 111-126

2012

  1. A pathogenic mechanism in huntington's disease involves small CAG-repeated RNAs with neurotoxic activity

    PLoS Genetics, Vol. 8, Núm. 2

  2. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

    Human Molecular Genetics, Vol. 21, Núm. 3, pp. 495-510